Sökning: id:"swepub:oai:DiVA.org:uu-279996" >
Development of a Wh...
Development of a Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin methanesulfonate (CMS) in Rat
-
- Bouchene, Salim (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Marchand, Sandrine (författare)
- INSERM U-1070, Pôle Biologie Santé, Poitiers, France; Laboratoire de Toxicologie et Pharmacocinétique, CHU de Poitiers, Poitiers, France; UFR Medecine et Pharmacie, Poitiers, France
-
- Couet, William (författare)
- INSERM U-1070, Pôle Biologie Santé, Poitiers, France; Laboratoire de Toxicologie et Pharmacocinétique, CHU de Poitiers, Poitiers, France; UFR Medecine et Pharmacie, Poitiers, France
-
visa fler...
-
- Friberg, Lena E. (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Gobin, Patrice (författare)
- INSERM U-1070, Pôle Biologie Santé, Poitiers, France
-
- Lamarche, Isabelle (författare)
- INSERM U-1070, Pôle Biologie Santé, Poitiers, France
-
- Grégoire, Nicolas (författare)
- INSERM U-1070, Pôle Biologie Santé, Poitiers, France; Laboratoire de Toxicologie et Pharmacocinétique, CHU de Poitiers, Poitiers, France
-
- Björkman, Sven (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Karlsson, Mats O. (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
visa färre...
-
(creator_code:org_t)
- Engelska.
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- Colistin is a polymyxin antibiotic which is used to treat patients infected with multidrug resistant Gram negative bacteria (MDR-GNB). The objective of this work was to develop a whole-body physiologically based pharmacokinetic (WBPBPK) model in rat for colistin and its prodrug, CMS. The Kp prior values of colisin and CMS used in the WBPBPK model were either measured ex vivo in rat tissue homogenates or calculated using an in silico model. The PK parameters were estimated fitting plasma concentrations from rats receiving an i.v. bolus of CMS. In the WBPBPK model, the tissue distribution was assumed to be well-stirred and perfusion-limited. Three scenarios were investigated: estimating the Kp values using in silico Kp prior values (I), estimating the Kp values using the Kp prior values from ex vivo experiments (II) and fixing the Kp values to the experimental ex vivo Kp values (III). The WBPBPK model well described CMS and colistin plasma concentration-time profiles. Colistin Kp values in kidneys were higher than in the other tissues. The predicted concentrations in tissue were highest for kidneys and brain which might be due to a high affinity for these tissues and/or active transport processes that remain poorly elucidated. The clearance estimates of CMS and colistin were in agreement with previously reported values in the literature. The model developed in this study might be a valuable tool in drug development to understand the disposition of colistin or new polymyxin candidates as well as to guide for optimal dosing regimens.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Nyckelord
- colistin
- CMS
- WBPBPK model
- tissue distribution
- PBPK
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas